Morgan Lewis

Pharmaceuticals and Biologics Upcoming Events

Related Publications

02/01/13 Comparative Effectiveness Research: Impact on Biopharmaceutical Development, Pricing, and Promotion, presented at the Biotechnology Industry Organization General Counsels Committee Winter Meeting, San Francisco
(pdf)
01/16/13 Minimizing FCA Liability Attaching to Price Reporting when Making Reasonable Assumptions, presented at the American Conference Institute’s 10th National Rx Drug Pricing Boot Camp
(pdf)
07/25/12 FDA User Fee Act Full of Surprises for Pharma and Biotech
FDA user fee reauthorization law expands fees to include generic and biosimilar applications, and includes a new emphasis on drug supply chain safety and incentives for development of new therapies.
View all publications

Related News

05/15/13 Pharma Cos. Smell Victory In Push For Drug-Tracking System, Law360
Life Sciences partner Stephen Paul Mahinka is quoted.
05/08/13 Draft Senate Bill on Drug Compounding Does Not Go Far Enough, Stakeholders Say, BNA's Health Care Daily Report
FDA & Healthcare associate Lee H. Rosebush is quoted.
04/23/13 FDA's OxyContin Ruling May Spur New Battles Over Generics, Law360
FDA partner Rebecca Dandeker comments on the recent FDA ruling to block generic versions of the painkiller OxyContin.
View all news
Title Event Type Start Date End Date